Susanne Johansson
5PUBLICATIONS
8CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Feb 18, 2025
The effect of severe renal impairment on the pharmacokinetics, safety and tolerability of balcinrenone.Chandrali S Bhattacharya, Hans Ericsson, Susanne Johansson
|Nov 05, 2024
Concentration-QT modeling demonstrates that the selective mineralocorticoid receptor modulator, balcinrenone (AZD9977), does not prolong QT interval.Jesper Sundell, Dinko Rekic, Johanna Melin
|Jul 05, 2023
Mass Balance and Absorption, Distribution, Metabolism, and Excretion Properties of Balcinrenone following Oral Administration in Combination with Intravenous Microtracer in Healthy Subjects.Bo Lindmark, Xue-Qing Li, Chandrali Bhattacharya
|Dec 12, 2022
Verinurad does not prolong QTc interval: a thorough QT study using concentration-QTc modelling.Joanna Parkinson, Corina Dota, Christian Källgren
|May 20, 2022
Pharmacokinetics, pharmacodynamics, and safety of verinurad with and without allopurinol in healthy Asian, Chinese, and non-Asian participants.Susanne Johansson, David Han, Thomas Hunt
Pageof 1
